SCHEMBL17248396

SCHEMBL17248396

c1ccc(-n2c3ccccc3c3cc(-c4cccc(-c5ccc6c(c5)c5ccccc5n6-c5cccc6c5sc5ccccc56)c4)ccc32)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.43
ATM Q13315 2/20 0.43
KDM4E B2RXH2 1/20 0.43
ALOX5 P09917 1/20 0.40
TNKS O95271 1/20 0.37
TNKS2 Q9H2K2 1/20 0.37
HSD17B10 Q99714 1/20 0.34
ALDH1A1 P00352 3/20 0.33
PRKDC P78527 1/20 0.33
TSPO P30536 1/20 0.33
LIMK1 P53667 1/20 0.33
KMT2A Q03164 3/20 0.33
IL1R1 P14778 1/20 0.33
MAPT P10636 3/20 0.32
MEN1 O00255 2/20 0.32
HTT P42858 1/20 0.32
PTGER4 P35408 1/20 0.32
RXFP1 Q9HBX9 1/20 0.32
GAA P10253 1/20 0.32
HDAC4 P56524 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26060211 0.98 L3MBTL1 (0.43) L3MBTL1ATMKDM4EALOX5TNKS
SCHEMBL25941179 0.98 L3MBTL1 (0.43) L3MBTL1ATMKDM4EALOX5TNKS
SCHEMBL10331557 0.98 ATM (0.45) L3MBTL1ATMKDM4EALOX5TNKS
SCHEMBL2549789 0.98 ATM (0.45) L3MBTL1ATMKDM4EALOX5TNKS
SCHEMBL30021388 0.98 ATM (0.45) L3MBTL1ATMKDM4EALOX5TNKS
SCHEMBL10331556 0.98 ATM (0.45) L3MBTL1ATMKDM4EALOX5TNKS
SCHEMBL10331507 0.98 ATM (0.45) L3MBTL1ATMKDM4EALOX5TNKS
SCHEMBL15685602 0.96 ATM (0.44) L3MBTL1ATMKDM4EALOX5TNKS
SCHEMBL19009389 0.95 ALOX5 (0.38) L3MBTL1ATMKDM4EALOX5TNKS
SCHEMBL19009378 0.95 ALOX5 (0.38) L3MBTL1ATMKDM4EALOX5TNKS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10361378-B2 Organic electroluminescent device NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) 2019-07-23 US disclosed
EP-2933851-B1 ORGANIC ELECTROLUMINESCENT DEVICE NIPPON STEEL & SUMIKIN CHEM CO (JP) 2017-05-10 EP disclosed
US-20150325796-A1 ORGANIC ELECTROLUMINESCENT DEVICE NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) 2015-11-12 US disclosed
US-20150325796-A1 ORGANIC ELECTROLUMINESCENT DEVICE NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) 2015-11-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10361378-B2 Organic electroluminescent device ELF3, DDT, LEF1 L3MBTL1 74/4885ATM 3768/4885KDM4E 1228/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.